FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe FTC published an interim report on how PBMs and GPOs influence drug costs and access, and harm independent pharmacies. The report details the market concentration, self-preferencing, and unfair contract terms of the six largest PBMs and three GPOs.
FTC Deepens Inquiry into Prescription Drug Middlemen
WEBMay 17, 2023 · The FTC is examining the practices of pharmacy benefit managers (PBMs) and their impact on the access and affordability of prescription drugs. The FTC has issued compulsory orders to two group purchasing organizations (GPOs) that negotiate drug rebates on behalf of PBMs.
How FTC's Battle With PBMs Could Reshape The Pharmaceutical ... - Forbes
WEBJul 20, 2024 · Now, PBMs are center stage for the FTC. The Federal Trade Commission has turned its attention to these powerful intermediaries and is, according to the Wall Street Journal, considering a...
FTC Launches Inquiry Into Prescription Drug Middlemen Industry
WEBJun 7, 2022 · The FTC will scrutinize the impact of vertically integrated pharmacy benefit managers on the access and affordability of prescription drugs. The agency will send compulsory orders to six PBMs and examine their business practices, fees, rebates, formularies, and policies.
Pharmacy benefit managers profit at expense of patients and small ... - CNN
WEBJul 9, 2024 · Pharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of millions of Americans, are racking up profits while squeezing patients and independent...
FTC to sue PBMs over drug prices including insulin, source says
WEBJul 10, 2024 · The Federal Trade Commission plans to file lawsuits against three large pharmacy benefit managers, or PBMs, for allegedly inflating costs of medications such as insulin, a source said. The...
FTC Accuses Drug Managers Of Squeezing Patients And Pharmacies - Forbes
WEBJul 11, 2024 · The FTC blasted pharmacy benefit managers, accusing them of raising patients’ costs and driving pharmacies out of business. The FTC is planning to sue the 3 largest PBMs.
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
WEBJul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug costs...
FTC says prescription middlemen are squeezing Main Street ... - CBS News
WEBJul 9, 2024 · Prescription drug middlemen — also known as pharmacy benefit managers — are lining their pockets by inflating drug prices, including overcharging cancer patients, the Federal Trade Commission...
Cigna’s PBM Express Scripts sues the FTC, seeking ... - MarketWatch
WEB3 days ago · Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the agency’s July report on the PBM industry was biased and defamatory ...
Skip to content